LEXICON PHARMACEUTICALS, INC. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LEXICON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LEXICON PHARMACEUTICALS, INC. for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 3.31 | 12,000 | 39,720 | 50,980 | |
| Mar 16 2021 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Sell | S | 6.93 | 12,000 | 83,100 | 71,766 | 83.8 K to 71.8 K (-14.33 %) |
| Mar 16 2021 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 3.31 | 12,000 | 39,720 | 83,766 | 71.8 K to 83.8 K (+16.72 %) |
| Mar 16 2021 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Sell | S | 6.90 | 10,912 | 75,340 | 71,766 | 82.7 K to 71.8 K (-13.20 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 30,467 | 0 | 60,933 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 25,290 | 0 | 25,290 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 9,555 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Option Exercise | M | 0.00 | 2,797 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Payment of Exercise | F | 7.19 | 26,584 | 191,139 | 157,020 | 183.6 K to 157 K (-14.48 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 30,467 | 0 | 183,604 | 153.1 K to 183.6 K (+19.90 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 25,290 | 0 | 153,137 | 127.8 K to 153.1 K (+19.78 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 9,555 | 0 | 127,847 | 118.3 K to 127.8 K (+8.08 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | WADE JEFFREY L | EVP, Corp Adm Affai ... | Buy | M | 0.00 | 2,797 | 0 | 118,292 | 115.5 K to 118.3 K (+2.42 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 28,690 | 0 | 57,380 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 26,600 | 0 | 26,600 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 9,727 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 7.19 | 16,560 | 119,066 | 120,791 | 137.4 K to 120.8 K (-12.06 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 28,690 | 0 | 137,351 | 108.7 K to 137.4 K (+26.40 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 26,600 | 0 | 108,661 | 82.1 K to 108.7 K (+32.41 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 9,727 | 0 | 82,061 | 72.3 K to 82.1 K (+13.45 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 72,334 | 69.3 K to 72.3 K (+4.31 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Option Exercise | M | 0.00 | 23,300 | 0 | 46,600 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Option Exercise | M | 0.00 | 22,374 | 0 | 22,373 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Option Exercise | M | 0.00 | 8,297 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Option Exercise | M | 0.00 | 2,497 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Payment of Exercise | F | 7.19 | 20,413 | 146,769 | 140,695 | 161.1 K to 140.7 K (-12.67 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Buy | M | 0.00 | 23,300 | 0 | 161,108 | 137.8 K to 161.1 K (+16.91 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Buy | M | 0.00 | 22,374 | 0 | 137,808 | 115.4 K to 137.8 K (+19.38 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Buy | M | 0.00 | 8,297 | 0 | 115,434 | 107.1 K to 115.4 K (+7.74 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | MAIN ALAN J | EVP, Innov & Chem S ... | Buy | M | 0.00 | 2,497 | 0 | 107,137 | 104.6 K to 107.1 K (+2.39 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 21,030 | 0 | 42,060 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 11,100 | 0 | 11,100 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 5,118 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Option Exercise | M | 0.00 | 1,517 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Payment of Exercise | F | 7.19 | 14,860 | 106,843 | 73,637 | 88.5 K to 73.6 K (-16.79 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 21,030 | 0 | 88,497 | 67.5 K to 88.5 K (+31.17 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 11,100 | 0 | 67,467 | 56.4 K to 67.5 K (+19.69 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 5,118 | 0 | 56,367 | 51.2 K to 56.4 K (+9.99 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | Crum Brian T | VP, General Counsel ... | Buy | M | 0.00 | 1,517 | 0 | 51,249 | 49.7 K to 51.2 K (+3.05 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 84,630 | 0 | 169,260 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 79,380 | 0 | 79,380 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 23,513 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Option Exercise | M | 0.00 | 5,362 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Payment of Exercise | F | 7.19 | 55,038 | 395,723 | 436,713 | 491.8 K to 436.7 K (-11.19 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 84,630 | 0 | 491,751 | 407.1 K to 491.8 K (+20.79 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 79,380 | 0 | 407,121 | 327.7 K to 407.1 K (+24.22 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 23,513 | 0 | 327,741 | 304.2 K to 327.7 K (+7.73 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | COATS LONNEL | President and CEO | Buy | M | 0.00 | 5,362 | 0 | 304,228 | 298.9 K to 304.2 K (+1.79 %) |